Before you sell to, join or invest in Ibex Biosciences, Inc.
MentionFox check on Ibex Biosciences, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/ibex-biosciences-inc-form-d-25000001
Check Ibex Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Ibex Biosciences, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Ibex Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-20.
Ibex Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 20, 2025. The filing reports $70K sold. Its industry group is Biotechnology. It names Alberto Croci (Executive Officer, Director), Michael Karlin (Executive Officer, Director), Roy Feinson (Director) (SEC Form D, February 20, 2025).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Ibex Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ibex Biosciences, Inc.
Free to see. No signup.
Get an email when Ibex Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Ibex Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ibex Biosciences, Inc. →Get the full cited report on Ibex Biosciences, Inc.
What the filing shows about Ibex Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ibex Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Ibex Biosciences, Inc.'s address as 9610 Medical Center Drive, Rockville, MD 20850.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Ibex Biosciences, Inc. is a registered filer with the SEC (CIK 1798553) and has filed since 2025-02-20. 1 filing is on record, the latest on 2025-02-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Ibex Biosciences, Inc.'s Form D of 2025-02-20 names Alberto Croci, Michael Karlin, Roy Feinson and 1 more as its officers, directors or promoters.
Its new offerings report $70K sold across 1 offering, as its own filings state.
Trailing twelve months. 765 filings in Biotechnology, totalled by week.
Alberto Croci is named as Executive Officer and Director on the Form D that Ibex Biosciences, Inc. filed with the SEC on 20 February 2025, one of 4 people that filing names.
Michael Karlin is named as Executive Officer and Director on the Form D that Ibex Biosciences, Inc. filed with the SEC on 20 February 2025, one of 4 people that filing names.
Roy Feinson is named as Director on the Form D that Ibex Biosciences, Inc. filed with the SEC on 20 February 2025, one of 4 people that filing names.
Sylvan Karlin is named as Director on the Form D that Ibex Biosciences, Inc. filed with the SEC on 20 February 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-02-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Ibex Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ibex Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ibex Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ibex Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ibex Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Ibex Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Washington, DC
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ibex-biosciences-inc-form-d-25000001